.
BioEnterprise

Nervomatrix

Nervomatrix is commercializing an FDA approved technology that combines the action of mapping peripheral nerve endings associated with pain and providing intense electrical stimulation at these points.

Funding

Everett Partners, Startvest, Targetech

Stage

Commercial